SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Toxicology and Industrial Health
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, M. G.
Right arrow Articles by Fraire, A. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, M. G.
Right arrow Articles by Fraire, A. E
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An assessment of asbestos body formation in extrapulmonary sites: liver and spleen

Marion Glenn Williams

The University of Texas Health Center At Tyler, Tyler, Texas, USA

Ronald F Dodson

The University of Texas Health Center At Tyler, Tyler, Texas, USA, ronald.dodson{at}uthct.edu

Eric W Dickson

University of Massachusetts Medical Center, Worcester, Massachusetts, USA

Armando E Fraire

University of Massachusetts Medical Center, Worcester, Massachusetts, USA

Study Objectives: Asbestos bodies (ABs) form as asbestos fibers become coated by a cellular iron- and protein-rich matrix. ABs have been reported in lymph nodes and a few extrapulmonary sites, but no data exist as to their formation outside of the lung. It is not clear whether the AB found in these extrapulmonary areas have been transported as mature structures from the lung or formed at the extrapulmonary site. This study was designed to determine if ABs are produced in extrapulmonary sites. The guinea pig efficiently forms ferruginous bodies in the lung and so it was chosen as a model to test the coating efficiency of amosite asbestos fibers in lung, liver and spleen. Design: Sized amosite asbestos (5 mg) was administered either endotracheally into lung (n=2) or directly into liver (n=4) and spleen (n=4) of healthy 10-week-old male guinea pigs. The lung, liver and splenic tissues were removed at 40 and 180 days post inoculation and were examined histologically for the presence of AB via light microscopy. Uncoated fibers isolated from the tissues were characterized by electron microscopy. The coating efficiency was calculated as a ratio of uncoated/coated fibers per organ. Results: The coating efficiency ratios of fibers that were collected at 40 days post-injection from the individual sites were: lung—350:1, liver—4200:1, and spleen—220,000:1. At 6 months post-injection the ratios for the individual sites consisted of: lung—176:1, liver—11,000:1, and spleen—1000:1. Conclusion: This study indicates that AB can be formed in extrapulmonary sites and that the coating efficiency in the lung is much greater than that within the liver or spleen.

Key Words: asbestos • asbestos bodies • electron microscopy • extrapulmonary site

Toxicology and Industrial Health, Vol. 17, No. 1, 1-6 (2001)
DOI: 10.1191/0748233701th090oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
G. Ritter, R. Wilson, F. Pompei, and D. Burmistrov
The multistage model of cancer development: some implications
Toxicology and Industrial Health, August 1, 2003; 19(7-10): 125 - 145.
[Abstract] [PDF]



Advertisement